Showing 20 of 47 recruiting trials for “primary-cutaneous-anaplastic-large-cell-lymphoma”
Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
👨⚕️ Jonathan Brammer, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Feb 2026View details ↗
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)
Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
👨⚕️ Robert Stuver, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Aug 2025View details ↗
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
👨⚕️ Christopher Jensen, MD MSCR, UNC Lineberger Comprehensive Cancer Center📍 1 site📅 Started Jun 2025View details ↗
CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas
👨⚕️ Tengyu Wang, Ph.D, Beijing GoBroad Hospital, Beijing, Beijing 102200📍 3 sites📅 Started Jun 2025View details ↗
RecruitingNCT07132567 ↗
Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance
CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas
A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA
RecruitingNCT06588868 ↗
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
👨⚕️ Pietro Quaglino, MD, SC Dermatologia U - A.O.U. Città della Salute e della Scienza di Torino📍 18 sites📅 Started Feb 2025View details ↗
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL
A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma
RecruitingNCT07003100 ↗
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies
RecruitingNCT06436677 ↗
A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma
Page 1 of 3Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →